Annual Shareholders Equity
$654.95 M
-$178.30 M-21.40%
December 31, 2023
Summary
- As of February 26, 2025, LYEL annual stockholders equity is $654.95 million, with the most recent change of -$178.30 million (-21.40%) on December 31, 2023.
- During the last 3 years, LYEL annual shareholders equity has fallen by -$63.49 million (-8.84%).
- LYEL annual shareholders equity is now -29.56% below its all-time high of $929.79 million, reached on December 31, 2021.
Performance
LYEL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$530.70 M
-$35.80 M-6.32%
September 30, 2024
Summary
- As of February 26, 2025, LYEL quarterly stockholders equity is $530.70 million, with the most recent change of -$35.80 million (-6.32%) on September 30, 2024.
- Over the past year, LYEL quarterly shareholders equity has dropped by -$124.25 million (-18.97%).
- LYEL quarterly shareholders equity is now -48.07% below its all-time high of $1.02 billion, reached on June 30, 2021.
Performance
LYEL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
LYEL Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.4% | -19.0% |
| 3 y3 years | -8.8% | -42.9% |
| 5 y5 years | +60.5% | -48.1% |
LYEL Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.6% | at low | -42.9% | at low |
| 5 y | 5-year | -29.6% | +60.5% | -48.1% | at low |
| alltime | all time | -29.6% | +60.5% | -48.1% | at low |
Lyell Immunopharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $530.70 M(-6.3%) |
| Jun 2024 | - | $566.50 M(-6.1%) |
| Mar 2024 | - | $603.16 M(-7.9%) |
| Dec 2023 | $654.95 M(-21.4%) | $654.95 M(-6.1%) |
| Sep 2023 | - | $697.57 M(-5.3%) |
| Jun 2023 | - | $736.86 M(-6.0%) |
| Mar 2023 | - | $783.83 M(-5.9%) |
| Dec 2022 | $833.25 M | $833.25 M(+1.6%) |
| Sep 2022 | - | $820.03 M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $868.04 M(-1.5%) |
| Mar 2022 | - | $881.25 M(-5.2%) |
| Dec 2021 | $929.79 M(+29.4%) | $929.79 M(-5.7%) |
| Sep 2021 | - | $986.47 M(-3.5%) |
| Jun 2021 | - | $1.02 B(+51.0%) |
| Mar 2021 | - | $676.92 M(-5.8%) |
| Dec 2020 | $718.44 M(+76.1%) | - |
| Dec 2020 | - | $718.44 M |
| Dec 2019 | $408.06 M | - |
FAQ
- What is Lyell Immunopharma annual stockholders equity?
- What is the all time high annual shareholders equity for Lyell Immunopharma?
- What is Lyell Immunopharma annual shareholders equity year-on-year change?
- What is Lyell Immunopharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly shareholders equity year-on-year change?
What is Lyell Immunopharma annual stockholders equity?
The current annual shareholders equity of LYEL is $654.95 M
What is the all time high annual shareholders equity for Lyell Immunopharma?
Lyell Immunopharma all-time high annual stockholders equity is $929.79 M
What is Lyell Immunopharma annual shareholders equity year-on-year change?
Over the past year, LYEL annual stockholders equity has changed by -$178.30 M (-21.40%)
What is Lyell Immunopharma quarterly stockholders equity?
The current quarterly shareholders equity of LYEL is $530.70 M
What is the all time high quarterly shareholders equity for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly stockholders equity is $1.02 B
What is Lyell Immunopharma quarterly shareholders equity year-on-year change?
Over the past year, LYEL quarterly stockholders equity has changed by -$124.25 M (-18.97%)